GENESEE VALLEY TRUST CO - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GENESEE VALLEY TRUST CO ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$200,000
-23.4%
2,314
-47.0%
0.08%
-25.7%
Q4 2017$261,000
-1.5%
4,366
-60.5%
0.11%
+0.9%
Q3 2017$265,000
+21.0%
11,061
-1.1%
0.11%
+16.1%
Q2 2017$219,000
-17.4%
11,181
-1.1%
0.09%
-48.9%
Q1 2017$265,000
+89.3%
11,306
-0.9%
0.18%
+83.8%
Q4 2016$140,000
-33.0%
11,414
-6.4%
0.10%
-22.7%
Q3 2016$209,000
+20.8%
12,189
+0.4%
0.13%
+14.3%
Q2 2016$173,000
+9.5%
12,135
+5.7%
0.11%
+4.7%
Q1 2016$158,000
-27.5%
11,485
-11.0%
0.11%
-25.2%
Q4 2015$218,000
+53.5%
12,910
-0.2%
0.14%
+52.1%
Q3 2015$142,000
-10.1%
12,940
+2.2%
0.09%
-7.8%
Q2 2015$158,000
+11.3%
12,660
-2.1%
0.10%
+15.9%
Q1 2015$142,000
-29.0%
12,925
+0.3%
0.09%
-31.2%
Q4 2014$200,000
-9.1%
12,885
-29.4%
0.13%
-6.6%
Q3 2014$220,000
-4.8%
18,250
+1.2%
0.14%
-1.4%
Q2 2014$231,000
+5.5%
18,040
-0.3%
0.14%
+0.7%
Q1 2014$219,000
+5.8%
18,100
-0.8%
0.14%
+0.7%
Q4 2013$207,000
+8.9%
18,250
+0.5%
0.14%
-2.1%
Q3 2013$190,000
-10.4%
18,160
-0.9%
0.14%
-15.7%
Q2 2013$212,00018,3200.17%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2015
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders